Share

December 2016; 6 (6) Review

Memory loss

Five new things

Ferenc Deak, Nidhi Kapoor, Calin Prodan, Linda A. Hershey
First published November 10, 2016, DOI: https://doi.org/10.1212/CPJ.0000000000000314
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
468

Share

Article Information

vol. 6 no. 6 523-529
DOI: 
https://doi.org/10.1212/CPJ.0000000000000314
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received June 19, 2016
  • Accepted July 25, 2016
  • First Published November 10, 2016.

Article Versions

Copyright & Usage: 
© 2016 American Academy of Neurology

Author Disclosures

    1. Ferenc Deak, MD, PhD,
    2. Nidhi Kapoor, MD,
    3. Calin Prodan, MD and
    4. Linda A. Hershey, MD, PhD
  1. Ferenc Deak, MD, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. associate editor of AGE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Oklahoma Center for the Advancement of Science and Technology (OCAST),#H-13-041 role: PI, 2013-2016

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Presbyterian Health Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Nidhi Kapoor, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Calin Prodan, MD and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. United States Department of Veterans Affairs Clinical Science Research & Development Service (Award Number 1I01CX000340) 2015-2109

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Presbyterian Health Foundation - Collaborative Pilot Grant 2015

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Linda A. Hershey, MD, PhD
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. . I received honoraria for talks at the Annual Primary Care Conferences on 5/5/14 & 5/5/15.

    Editorial Boards:

    1. I have served on the editorial board of Neurology since 2010. I am on the editorial board of JSM Alzheimer's Disease & Related Dementia, 2014-present.

    Patents:

    1. NONE

    Publishing Royalties:

    1. I have received royalties for writing reviews about Memory Loss for MedLink Neurology since 2011. I also write a review for MedLink about cognitive and behavioral changes in PSP.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical procedures or imaging studies:

    1. I held an endowed chair at OU from 2010-2015: Ethelyn McElwee Endowed Chair in Alzheimer's Disease Research, University of Oklahoma Health Sciences Center and was the Director of Dementia & Behavioral Neurology at OU Physicians.

    Research Support, Commercial Entities:

    1. Dr. Hershey was the site PI for the Baxter study of IVIG in patients with Alzheimer disease (2012-2014). She was the site PI for the Forum Pharmaceuticals study of a new drug for Alzheimer's disease (2014-2015).

    Research Support, Government Entities:

    1. Dr. Hershey was co-investigator (5% effort) on a translational research study from the NIH(8UL1TR000041) about delivering the STOMP intervention in the home environment, 2013-14.

    Research Support, Academic Entities:

    1. She is the co-PI (5% effort)on an OUHSC VP for Research study to examine memory consolidation in elders with aMCI, 2014-2015. She was the co-PI for the Singer Seed Grant from the Oklahoma College of Nursing, 2014-2015.

    Research Support, Foundations and Societies:

    1. She was the co-PI of an OUHSC Presbyterian Health Foundation grant to study sleep in DLB-MCI compared to aMCI, 2014-2015. She was co-investigator on an Alzheimer's Association grant to study ways to reduce ADL disability in dementia, 2014-2016.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. I gave expert testimony during 2015 concerning a TBI pt. I gave expert testimony during 2016 concerning a stroke pt. The proceeds went to my department.

  1. University of Oklahoma Health Sciences Center, Oklahoma City.
  1. Correspondence to:
    linda-hershey{at}ouhsc.edu
View Full Text

Article usage

Article usage: November 2016 to August 2023

AbstractFullPdfSource
Nov 2016684036Highwire
Dec 2016188336124Highwire
Jan 20178042878Highwire
Feb 20178181238Highwire
Mar 2017304929Highwire
Apr 201716346Highwire
May 2017149310Highwire
Jun 201711444Highwire
Jul 20179238Highwire
Aug 20179537Highwire
Sep 20175724Highwire
Oct 20176922Highwire
Nov 20174224Highwire
Dec 20174425Highwire
Jan 20183841Highwire
Feb 20183744Highwire
Mar 20184931Highwire
Apr 201810510Highwire
Apr 201871722pmc
May 20188452Highwire
Jun 2018165104Highwire
Jun 20182911pmc
Jul 201811331Highwire
Aug 20189133Highwire
Aug 201841821pmc
Sep 20186300Highwire
Oct 20187411Highwire
Nov 20189321Highwire
Dec 20186011Highwire
Jan 20194222Highwire
Feb 20193800Highwire
Mar 20196400Highwire
Apr 20196231Highwire
May 20194311Highwire
Jun 20194400Highwire
Jul 20193822Highwire
Aug 20193400Highwire
Sep 20193900Highwire
Oct 20195204Highwire
Nov 20195102Highwire
Dec 20194600Highwire
Jan 20203911Highwire
Feb 20205510Highwire
Mar 20203800Highwire
Apr 20202530Highwire
May 20207400Highwire
Jun 20202801Highwire
Jul 20202910Highwire
Aug 20202100Highwire
Sep 20205122Highwire
Oct 20202930Highwire
Nov 20203821Highwire
Dec 20204101Highwire
Jan 20212100Highwire
Feb 202113142Highwire
Mar 20214501Highwire
Apr 20214510Highwire
May 202134110Highwire
Jun 20212900Highwire
Jul 202110300Highwire
Aug 202110011Highwire
Sep 20213410Highwire
Oct 20215532Highwire
Nov 20214241Highwire
Dec 20214800Highwire
Jan 20226323Highwire
Feb 20225211Highwire
Mar 20225700Highwire
Apr 20222733Highwire
May 20225901Highwire
Jun 20223111Highwire
Jul 20224601Highwire
Aug 20223232Highwire
Sep 20223800Highwire
Oct 20224201Highwire
Nov 20226800Highwire
Dec 20224000Highwire
Jan 20238100Highwire
Feb 20232701Highwire
Mar 20232611Highwire
Apr 20234700Highwire
May 20238900Highwire
Jun 20233700Highwire
Jul 20233510Highwire
Aug 20231400Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles